VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RFLRafael Holdings, Inc.
$2.76$101M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksRFLBalance Sheet

Rafael Holdings, Inc. (RFL) Balance Sheet

10Y historyFree accessUpdated daily

The company's financial position is characterized by a shrinking asset base, which contracted from $114.1 million in 2025Q4 to $92.0 million by 2026Q3.

RFL Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJul'25Jul'24Jul'23Jul'22Jul'21Jul'20Jul'19Jul'18Jul'17Jul'16
Total Current Assets34.86M56.71M72.5M82.94M108.35M14.76M9.83M13.26M44.51M12.17M2.61M
Cash & Short-Term Investments-----------
Cash Only30.5M52.77M2.67M21.5M26.54M7.85M6.21M12.02M15.8M11.76M2.34M
Short-Term Investments0063.27M58.01M36.7M00024.7M00
Accounts Receivable-----------
Days Sales Outstanding-----------
Inventory276K281K000000000
Days Inventory Outstanding399.9243.04---------
Other Current Assets3.79M786K430K914K44.81M5M3.23M00017K
Total Non-Current Assets57.13M57.39M24.33M15.89M9.97M139.29M126.52M128.88M72.41M74.04M61.7M
Property, Plant & Equipment1.52M1.6M2.12M1.7M1.77M1.84M44.43M48.73M50.11M51.16M50.97M
Fixed Asset Turnover0.63x0.57x0.30x0.16x0.23x0.44x0.11x0.10x0.09x0.11x0.11x
Goodwill19.94M19.94M3.05M00000000
Intangible Assets896K32.57M1.85M1.57M1.57M1.57M1.57M1.57M1.65M00
Long-Term Investments0----------
Other Non-Current Assets-----------
Total Assets91.99M114.11M96.83M98.83M118.32M154.06M136.35M142.14M116.92M86.2M64.31M
Asset Turnover0.01x0.01x0.01x0.00x0.00x0.01x0.04x0.03x0.04x0.07x0.09x
Asset Growth %42.51%17.84%-2.02%-16.47%-23.2%12.99%-4.08%21.57%35.63%34.05%-
Total Current Liabilities11.02M11.6M7.51M2.15M21.03M17.3M5.73M1.43M891K363K302K
Accounts Payable7.04M6.89M2.56M333K564K1.16M921K795K367K115K64K
Days Payables Outstanding10.51K5.96K6.06K--6.05K-----
Short-Term Debt-----------
Deferred Revenue (Current)0----------
Other Current Liabilities3.37M3.28M113K1.05M3.59M252K4.81M27K24K35K-278K
Current Ratio3.16x4.89x9.65x38.67x5.15x0.85x1.72x9.29x49.96x33.52x8.65x
Quick Ratio3.14x4.86x9.65x38.67x5.15x0.85x1.72x9.29x49.96x33.52x8.65x
Cash Conversion Cycle-10.11K----------
Total Non-Current Liabilities167K4.14M3.06M55K88K48K92K15.95M464K23.76M15.19M
Long-Term Debt2K78K73K000014.95M000
Capital Lease Obligations0----------
Deferred Tax Liabilities0----------
Other Non-Current Liabilities-----------
Total Liabilities11.19M15.74M10.57M2.2M21.11M17.35M5.82M17.38M1.35M24.13M15.5M
Total Debt610K692K2.39M015M14.53M014.95M000
Net Debt-29.89M-52.08M-288K-21.5M-11.54M6.67M-6.21M2.92M-15.8M-11.76M-2.34M
Debt / Equity0.01x0.01x0.03x-0.15x0.11x-0.12x---
Debt / EBITDA-0.02x----------
Net Debt / EBITDA0.83x---------6.22x-0.83x
Interest Coverage--49.45x-270.21x--23327.67x-1951.17x-81.95x-7.48x--59.60x
Total Equity80.8M98.37M86.26M96.63M97.21M136.7M130.53M124.76M115.56M62.08M48.81M
Equity Growth %39.63%14.04%-10.73%-0.59%-28.89%4.73%4.62%7.96%86.16%27.18%-
Book Value per Share1.583.343.634.154.928.278.289.409.264.953.89
Total Shareholders' Equity75.39M94.39M82.19M100.29M100.52M122.29M116.8M110.98M106.7M52.74M48.81M
Common Stock521K516K246K244K245K177K157K139K126K50.43M48.62M
Retained Earnings-252.72M-232.26M-201.74M-167.33M-165.46M-40.8M-16.25M-5.84M-1.11M00
Treasury Stock-168K-168K-168K00000000
Accumulated OCI4.52M4.14M111K3.37M3.7M3.77M3.76M3.78M4.04M2.32M189K
Minority Interest5.42M3.98M4.07M-3.66M-3.31M14.42M13.73M13.78M8.87M9.34M0

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetAdequate
Cash FlowBurning
Top Statement Risk

Clinical Trial Burn Rate

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Asset Base Shrinking Amidst Burn

According to recent quarterly filings, Rafael Holdings' total assets have contracted from $114.1 million in 2025Q4 to $92.0 million by 2026Q3, reflecting a consistent erosion of the balance sheet as the company funds its clinical-stage pharmaceutical operations through its existing cash reserves.

The steady decline in total assets suggests that the company is consuming its capital base to sustain operations rather than generating internal growth. Investors should monitor whether this trajectory leads to a critical liquidity threshold, as the current rate of asset depletion appears unsustainable without a strategic pivot or external capital infusion.

Cash Runway Facing Downward Pressure

As reported in financial statements, the company's cash position has declined from a peak of $52.8 million in 2025Q4 to $30.5 million in 2026Q3, indicating a rapid consumption of liquidity that warrants close attention from stakeholders evaluating the firm's long-term viability.

While the current ratio of 3.16 remains technically healthy, the absolute decline in cash reserves highlights the company's dependence on its existing balance sheet to cover ongoing R&D and administrative costs. This trend suggests that the company's liquidity buffer is narrowing, potentially limiting management's flexibility to pursue future clinical or real estate opportunities.

Accumulated Deficit Eroding Shareholder Value

Based on RFL's reported figures, the retained earnings deficit has deepened significantly to -$252.7 million as of 2026Q3, underscoring the persistent value destruction inherent in the company's current business model of funding high-risk oncology research through limited real estate income.

The widening deficit in retained earnings reflects the cumulative impact of years of operating losses, which continue to weigh heavily on the equity base. This trend suggests that the company's capital structure is increasingly reliant on its initial equity cushion, as the core business operations have yet to demonstrate a path toward profitability.

Goodwill Volatility Masks Asset Quality

Financial data from recent periods reveals significant fluctuations in goodwill, which spiked to $28.3 million in 2025Q3 before settling at $19.9 million, suggesting that the company's balance sheet is subject to non-operational accounting adjustments that may obscure the underlying value of its core assets.

The volatility in intangible assets warrants further investigation, as it may indicate periodic impairments or revaluations of the company's pharmaceutical interests. Investors should be cautious, as these accounting shifts can mask the true economic reality of the company's asset base and its ability to generate future returns.

RFL — Frequently Asked Questions

Quick answers to the most common questions about buying RFL stock.

What are the total assets of Rafael Holdings, Inc. (RFL)?

As of 2025, Rafael Holdings, Inc. (RFL) had total assets of $114.1M including $56.7M in current assets.

How much debt does Rafael Holdings, Inc. (RFL) have?

Rafael Holdings, Inc. (RFL) carries total debt of $0.7M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Rafael Holdings, Inc.?

Rafael Holdings, Inc. (RFL) has total shareholders' equity (book value) of $94.4M ($3.34 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Rafael Holdings, Inc.'s current ratio and liquidity?

Rafael Holdings, Inc. (RFL) reported a current ratio of 4.89x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.